These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 11335753)

  • 1. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry.
    Wajnrajch MP; Gertner JM; Huma Z; Popovic J; Lin K; Verlander PC; Batish SD; Giampietro PF; Davis JG; New MI; Auerbach AD
    Pediatrics; 2001 Apr; 107(4):744-54. PubMed ID: 11335753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine abnormalities in patients with Fanconi anemia.
    Giri N; Batista DL; Alter BP; Stratakis CA
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2624-31. PubMed ID: 17426088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small pituitary size in children with Fanconi anemia.
    Sherafat-Kazemzadeh R; Mehta SN; Care MM; Kim MO; Williams DA; Rose SR;
    Pediatr Blood Cancer; 2007 Aug; 49(2):166-70. PubMed ID: 17274008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine profiling in patients with Fanconi anemia, homozygous for a FANCG founder mutation.
    Dillon B; Feben C; Segal D; du Plessis J; Reynders D; Wainwright R; Poole J; Krause A
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1351. PubMed ID: 32529760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin and growth hormone serum levels during the clonidine test in children with short stature and variable growth hormone status.
    Stylianou C; Galli-Tsinopoulou A; Grammatikopoulou MG; Koliakos G; Varlamis G
    Hormones (Athens); 2011; 10(1):39-45. PubMed ID: 21349805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinopathies, Bone Health, and Insulin Resistance in Patients with Fanconi Anemia after Hematopoietic Cell Transplantation.
    Barnum JL; Petryk A; Zhang L; DeFor TE; Baker KS; Steinberger J; Nathan B; Wagner JE; MacMillan ML
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1487-1492. PubMed ID: 27180116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empty sella in short children with and without hypothalamic-pituitary abnormalities.
    Soliman AT; Darwish A; Asfour MG
    Indian J Pediatr; 1995; 62(5):597-603. PubMed ID: 10829929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi Anemia and Laron Syndrome.
    Castilla-Cortazar I; de Ita JR; Aguirre GA; Castorena-Torres F; Ortiz-Urbina J; García-Magariño M; de la Garza RG; Diaz Olachea C; Elizondo Leal MI
    Am J Med Sci; 2017 May; 353(5):425-432. PubMed ID: 28502327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and management of short stature in thalassaemia major.
    Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh.
    Maheshwari HG; Silverman BL; Dupuis J; Baumann G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4065-74. PubMed ID: 9814493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone secretory pattern and response to treatment in children with short stature followed to adult height.
    Radetti G; Buzi F; Cassar W; Paganini C; Stacul E; Maghnie M
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):27-33. PubMed ID: 12807500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional and total IGFBP3 for the assessment of disorders of the GH/IGF1 axis in children with chronic kidney disease, GH deficiency, or short stature after SGA status at birth.
    Büscher AK; Büscher R; Pridzun L; Langkamp M; Wachendorfer N; Hoyer PF; Ranke MB; Hauffa BP
    Eur J Endocrinol; 2012 May; 166(5):923-31. PubMed ID: 22318747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment: Retesting early in the course of GH treatment.
    Vuralli D; Gonc EN; Ozon ZA; Alikasifoglu A; Kandemir N
    Growth Horm IGF Res; 2017 Jun; 34():31-37. PubMed ID: 28511077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short stature and failure of pubertal development in thalassaemia major: evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion.
    Roth C; Pekrun A; Bartz M; Jarry H; Eber S; Lakomek M; Schröter W
    Eur J Pediatr; 1997 Oct; 156(10):777-83. PubMed ID: 9365067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrinopathies in adolescents with thalassaemia major receiving oral iron chelation therapy.
    Sharma R; Seth A; Chandra J; Gohain S; Kapoor S; Singh P; Pemde H
    Paediatr Int Child Health; 2016 Feb; 36(1):22-7. PubMed ID: 25311879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic differences between short children with GH peak levels in the lower normal range and healthy children of normal height.
    Tidblad A; Gustafsson J; Marcus C; Ritzén M; Ekström K
    Growth Horm IGF Res; 2017 Jun; 34():22-27. PubMed ID: 28482270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.